imatinib mesylate has been researched along with Age-Related Macular Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amirault, JC; de la Motte Rouge, T; Khaled, W; Vignot, S | 1 |
1 review(s) available for imatinib mesylate and Age-Related Macular Degeneration
| Article | Year |
|---|---|
[Non oncologic applications of molecular targeted therapies].
Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Benzamides; Bevacizumab; Drug-Eluting Stents; Humans; Imatinib Mesylate; Immunosuppressive Agents; Macular Degeneration; Molecular Targeted Therapy; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Rituximab; Scleroderma, Systemic; TOR Serine-Threonine Kinases | 2012 |